Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|9|979-987

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.9, 2006-04, pp. : 979-987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malonyl-CoA Decarboxylase Inhibition as a Novel Approach to Treat Ischemic Heart Disease

By Lopaschuk Gary   Stanley William  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 6, 2006-12 ,pp. : 433-439

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical Basis of Ischemic Heart Injury and of Cardioprotective Interventions

By  

Current Medicinal Chemistry, Vol. 14, Iss. 15, 2007-06 ,pp. : 1619-1637

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension and Ischemic Heart Disease in Women

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3885-3892

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Ischemic Heart Disease: Therapeutic Potential

By Symes J.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 3, 2001-03 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease

By  

Current Medicinal Chemistry, Vol. 20, Iss. 14, 2013-05 ,pp. : 1817-1823

Bentham Science Publishers

Access to resources Recommend Favorite